Fundz

Pyramid Biosciences, Inc. reported raising $33.5 Million in an initial SEC Form D filing

PRIVATEOct 15, 2021

Amount Raised

$33.5 Million

$33.5 Million sold, per SEC Form D (first sale Oct 15, 2021)

Round Type

Venture

WalthamBiotechnology

Who to call at Pyramid Biosciences, Inc., and when

A new round usually means Pyramid Biosciences, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Pyramid Biosciences, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Pyramid Biosciences, Inc., from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Pyramid Biosciences, Inc.

Location

330 Bear Hill Road

Waltham, Massachusetts, United States

About

Founded in 2015, Pyramid Biosciences, Inc. is a Boston-based, clinical stage, biotechnology company dedicated to developing a portfolio of precision therapies targeting a wide range of molecularly-defined diseases, regulated by the tropomyosin receptor kinase (TRK) family. Pyramid is currently in clinical development of two highly-selective TRK inhibitors. For more information, please visit www.pyramidbio.com

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Pyramid Biosciences, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Pyramid Biosciences, Inc.'s next move

See what Strategic adds

Pyramid Biosciences, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.